Corrigendum: Evaluation of Zn, Cu, and Se Levels in the North American Autism Spectrum Disorder Population

Front Mol Neurosci. 2022 Feb 14:15:831799. doi: 10.3389/fnmol.2022.831799. eCollection 2022.

Sunil Q Mehta^{1

2}, Supriya Behl³, Patrick L Day⁴, Adriana M Delgado³, Nicholas B Larson⁵, Lindsay R Stromback³, Andrea R Huebner^{1

2}, Timothy R DeGrado⁶, Jessica M Davis⁷, Paul J Jannetto⁴, Flora Howie^{1

2}, Mukesh K Pandey⁶

¹ Division of Developmental and Behavioral Pediatrics, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, United States.
² Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States.
³ Children's Research Center, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, United States.
⁴ Metals Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
⁵ Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States.
⁶ Divisions of Nuclear Medicine and Research, Department of Radiology, Mayo Clinic, Rochester, MN, United States.
⁷ Division of Community Pediatric and Adolescent Medicine, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, United States.

Abstract

[This corrects the article DOI: 10.3389/fnmol.2021.665686.].

Keywords: Cu; Se; Zn; autism spectrum disorder; biometals.